Hong Kong Pharmaceutical stocks continued to decline, and Qiming medical fell more than 14%
Hong Kong Pharmaceutical stocks continued to decline. As of press time, Qiming medical fell by more than 14%, Baiji Shenzhou fell by more than 13%, Corning Jerry pharmaceutical fell by more than 10%, kangfang biology fell by more than 7%, kangxinuo biology and Yaoming biology fell by more than 5%, and Yiming Kant and Fuxing medicine fell by more than 4%.
This text is a result of machine translation.
Related companies：
Briefing Jun 24, 2022 11:09 AM
· Technology
Russian finance minister says West creates artificial obstacles for Russia to repay public debt
In-depth
Jan 30, 2026 06:00 PM
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 10, 2022 02:39 PM
Briefing Jun 13, 2022 09:44 AM
· Healthcare
Cro plate fell, and Wuxi apptec fell nearly 10%
Briefing Jun 10, 2022 09:48 PM
Singaporean Prime Minister Lee Hsien Loong meets with weifenghe
Healthcare
CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist
The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.
Sep 06, 2022 11:48 AM
Briefing Jun 10, 2022 07:17 PM
Baiji Shenzhou PD-1 monoclonal antibody baizean ® The ninth indication was obtained and the first-line treatment for nasopharyngeal carcinoma was approved
Healthcare
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Briefing May 19, 2022 10:34 PM
· Healthcare
The new development bank issued 7 billion yuan of Panda Bonds for infrastructure projects in member countries
Briefing Apr 28, 2022 09:59 AM
A new breakthrough in the first-line treatment of advanced esophageal cancer: PD-1 monoclonal antibody baizean ® Global phase 3 clinical trials reached the primary end point
See more
Read next
Insight
In-depth
Technology · Interview
Exclusive Interview: NAVEE GOLF Is Building a Smart Golf Ecosystem, Starting with Push Carts
Yesterday 05:04 PM
Insight
In-depth
Embodied AI · Analysis
Chinese Embodied AI Company AI² Robotics: The Real Bottleneck in Embodied AI Is Scenarios, Not Just AI
Apr 14, 2026 11:25 AM
Insight
In-depth
Technology, Embodied AI · Analysis
From 0 to 2.6 million units, Ecovacs Window Robot makes "first choice" the only answer.
Apr 10, 2026 07:00 PM
Insight
In-depth